Alcoholism Clinical Trial
Official title:
Assessment and Treatment of People With Alcohol Drinking Problems
Verified date | September 8, 2015 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to gather information about people s drinking histories and to
evaluate them for other research studies being conducted at the National Institute on Alcohol
Abuse and Alcoholism (NIAAA). The evaluation will include a physical examination, blood
tests, an MRI scan of the brain and completion of various questionnaires about alcohol use
and mood. The information gathered from all of these tests will be used by researchers to
gain a better understanding of the disease of alcoholism and determine eligibility for other
NIAAA studies. This is an inpatient study so participants will stay at the NIH hospital for
at least three weeks and up to six weeks if a person is found to be eligible for other NIAAA
research studies.
The study is open to people age 18 and older whose alcohol drinking has caused significant
problems in their lives, and who desire alcoholism treatment. Detoxification will be provided
if needed, and each person may participate in our alcoholism treatment program. The treatment
includes group and individual counseling sessions as well as self-help meetings such as AA.
Family counseling and recreational opportunities are also an important part of the treatment
experience. The doctors, nurses, social workers and all of our other staff are committed to
helping participants design an aftercare program that will help them leave the hospital and
remain sober. Participants may also be able to attend a 12-week aftercare program in the
NIAAA outpatient clinic.
Status | Completed |
Enrollment | 1192 |
Est. completion date | September 8, 2015 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
- INCLUSION CRITERIA: Age greater than 18 years old. Are seeking help for alcohol drinking-related problems. EXCLUSION CRITERIA: People with medical problems that cannot be adequately managed at the NIH Clinical Center, as determined by the medically advisory investigator, in consultation with relevant Clinical Center consult services as needed. Serious neuro-psychiatric conditions which impair judgment or cognitive function to an extent that precludes them from providing informed consent, such as acute psychosis or severe dementia (incompetent individuals). People who are unlikely or unable to complete the treatment program because they become or are likely to be incarcerated while on the protocol. People who are required to receive treatment by a court of law or who are involuntarily committed to treatment. |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
United States,
COMBINE Study Research Group. Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods. Alcohol Clin Exp Res. 2003 Jul;27(7):1107-22. — View Citation
O'Brien CP. Treatment of alcoholism as a chronic disorder. Alcohol. 1994 Nov-Dec;11(6):433-7. Review. — View Citation
O'Connor PG, Schottenfeld RS. Patients with alcohol problems. N Engl J Med. 1998 Feb 26;338(9):592-602. Review. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05054738 -
CRP and S&A for Inpatient Veterans
|
N/A | |
Completed |
NCT02233738 -
Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services
|
N/A | |
Completed |
NCT05877807 -
Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
|
||
Completed |
NCT00000437 -
Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
|
Phase 4 | |
Completed |
NCT00536146 -
The Stress-Hormone System in Alcohol-Dependent Subjects
|
N/A | |
Terminated |
NCT00890149 -
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
|
Phase 2 | |
Completed |
NCT02939352 -
The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues
|
Early Phase 1 | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT01553136 -
Varenicline Treatment of Alcohol Dependence in Smokers
|
Phase 2 | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Completed |
NCT01389297 -
Overcoming Addictions: A Randomized Clinical Trial of a Web Application Based on SMART Recovery
|
N/A | |
Completed |
NCT01113164 -
Matching Genotypes and Serotonergic Medications for Alcoholism
|
Phase 1 | |
Completed |
NCT00768508 -
Combined Pharmacotherapies for Alcoholism
|
Phase 3 | |
Completed |
NCT01760785 -
Valproate for Mood Swings and Alcohol Use Following Head Injury
|
N/A | |
Completed |
NCT00127231 -
Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women
|
N/A | |
Terminated |
NCT02842528 -
Cognitive Vulnerability Factors in Alcohol-dependence
|
N/A | |
Completed |
NCT00367575 -
An Internet-based Intervention for Problem Drinking
|
N/A | |
Completed |
NCT00167687 -
Prazosin Alcohol Dependence IVR Study
|
Phase 4 | |
Completed |
NCT00583440 -
12-step Facilitation for the Dually Diagnosed
|
Phase 1/Phase 2 | |
Completed |
NCT00223639 -
New Medications to Treat Alcohol Dependence
|
Phase 2 |